Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.

MLA

Dhainaut, Jean-Francois, et al. “Extended Drotrecogin Alfa (Activated) Treatment in Patients with Prolonged Septic Shock.” Intensive Care Medicine, vol. 35, no. 7, July 2009, pp. 1187–95. EBSCOhost, https://doi.org/10.1007/s00134-009-1436-1.

APA

Dhainaut, J.-F., Antonelli, M., Wright, P., Desachy, A., Reignier, J., Lavoue, S., Charpentier, J., Belger, M., Cobas-Meyer, M., Maier, C., Mignini, M. A., & Janes, J. (2009). Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock. Intensive Care Medicine, 35(7), 1187–1195. https://doi.org/10.1007/s00134-009-1436-1

Chicago

Dhainaut, Jean-Francois, Massimo Antonelli, Patrick Wright, Arnaud Desachy, Jean Reignier, Sylvain Lavoue, Julien Charpentier, et al. 2009. “Extended Drotrecogin Alfa (Activated) Treatment in Patients with Prolonged Septic Shock.” Intensive Care Medicine 35 (7): 1187–95. doi:10.1007/s00134-009-1436-1.